Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-100251

Director acquired 1,603 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fust Matthew K · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-02-16 Exercise or conversion : show line 1 in the form +1,603 12,286 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2016-02-16 Exercise or conversion : show line 2 in the form Restricted Stock Units −1,603 1,603 13,354 D
Loading xslF345X03/doc4.xml…